dc.creatorRizek, Camila
dc.creatorFu, Liang
dc.creatorSantos, Leticia Cavalcanti dos
dc.creatorLeite, Gleice
dc.creatorRamos, Jessica
dc.creatorRossi, Flavia
dc.creatorGuimaraes, Thais
dc.creatorLevin, Anna S
dc.creatorCosta, Silvia Figueiredo
dc.date.accessioned2015-05-05T18:35:32Z
dc.date.accessioned2018-07-04T17:04:56Z
dc.date.available2015-05-05T18:35:32Z
dc.date.available2018-07-04T17:04:56Z
dc.date.created2015-05-05T18:35:32Z
dc.date.issued2014
dc.identifierAnnals of Clinical Microbiology and Antimicrobials. 2014 Sep 02;13(1):43
dc.identifierhttp://dx.doi.org/10.1186/s12941-014-0043-3
dc.identifierhttp://www.producao.usp.br/handle/BDPI/48778
dc.identifier10.1186/s12941-014-0043-3
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1644400
dc.description.abstractAbstract Background Carbapenemase genes are one of the most frequent mechanisms reported in carbapenem-resistant P. aeruginosa; however, description of P. aeruginosa co-harbouring two or more carbapenemases is unusual. Methods In this study we evaluated the presence of carbapenemase genes and the clonality of P. aeruginosa isolates obtained from a hospital over a 12-year period. A total of 127 isolates of carbapenem-resistant P. aeruginosa recovered from 109 patients feces (four samples), rectal swab (three samples), nasal swab (one sample) and anal abscess (one sample), were evaluated. Minimum inhibitory concentrations of the following antibiotics imipenem, meropenem and polymyxin E were determined by broth microdilution. The molecular profile of isolates was evaluated by pulsed field gel electrophoresis (PFGE). PCR for the following carbapenemase genes bla IMP; bla SPM; bla VIM; bla SIM; bla NDM; bla KPC; bla GES and nucleotide sequencing to confirm the enzyme gene types were performed and compared with the database available on the Internet (BLAST- http://www.ncbi.nlm.nhi.gov/blast/ ). Results All isolates were carbapenem-resistant, their MIC50 and MIC90 were respectively 64 μg/mL and 256 μg/mL to imipenem and 32 μg/mL and 256 μg/mL to meropenem, all isolates except one (MIC = 8 mg/L) were susceptible to polymyxin E. The most frequent carbapenemase genes identified were bla SPM identified in 41 isolates (32%), followed by 10 with bla kpc and 5 with bla VIM (3.9%). All belonged to the class SPM-1 and VIM-2. In 2011, one isolate harbouring three carbapenemase genes (SPM-1, VIM-2 and KPC-2) that belonged to a new clone was identified in a hematopoietic stem cell transplanted patient. Then, 19 carbapenem-resistant P. aeruginosa were identified in an outbreak that occurred in the bone marrow transplant unit, all positive for SPM-1 gene, and 9 (47.3%) harbored both SPM-1 and KPC. Conclusion Our findings showed that PCR for KPC gene should be performed to evaluate carbapenem resistance in P. aeruginosa and that this agent can harbor more than one carbapenemase gene. Attention should be focused on the possible rapid spread of KPC in P. aeruginosa isolates and for the fact that P. aeruginosa may become a reservoir of this transmissible resistance mechanism.
dc.languageen
dc.publisherBioMed Central
dc.relationAnnals of Clinical Microbiology and Antimicrobials
dc.rightsRizek et al.; licensee BioMed Central Ltd.
dc.rightsopenAccess
dc.subjectPseudomonas
dc.subjectCarbapenemases
dc.subjectKPC
dc.subjectVIM
dc.subjectSPM
dc.titleCharacterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución